Three Major Regulators Launch Pilot To Reduce Duplication Of GMP Inspections
Executive Summary
Regulatory bodies from Australia, Canada and the UK say a new pilot program will reduce the need for multiple inspections of the same site, while an MoU signed by Australia and Canada will cut the amount of documentary evidence required from drug sponsors seeking GMP clearances.